Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?

Area of Science:

• Neuroscience
• Neurology
• Pharmacology

Background:

• Parkinson's disease (PD) was historically viewed as a motor disorder linked to dopaminergic neuron loss.
• Recent understanding recognizes PD's pathology extends beyond the substantia nigra, affecting other brain regions and the nervous system.
• Non-motor symptoms like cognitive impairment and autonomic dysfunction are prevalent and not solely explained by nigral pathology.

Purpose of the Study:

• To review cognitive impairment and affective symptoms in Parkinson's disease.
• To evaluate the suitability of rodent models for studying these non-motor deficits.
• To emphasize the need for effective models to develop novel therapeutic strategies.

Main Methods:

• Literature review focusing on Parkinson's disease non-motor symptoms.
• Analysis of existing rodent models for their capacity to replicate cognitive and affective deficits.
• Examination of behavioral tasks used to assess these symptoms in preclinical models.

Main Results:

• Standard dopamine replacement therapy is often insufficient for non-motor symptoms in PD.
• Rodent models offer a platform for investigating the mechanisms behind PD's cognitive and affective features.
• Understanding model limitations is key to advancing treatment evaluation.

Conclusions:

• Parkinson's disease involves complex non-motor symptoms requiring broader therapeutic approaches.
• Appropriate rodent models are essential for developing and testing new treatments for these neuropsychological aspects of PD.
• Improved preclinical models will facilitate the discovery of effective strategies for PD patients.